• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

shRNA 介导的 KNTC1 敲低通过调节 PSMB8 抑制非小细胞肺癌。

shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8.

机构信息

Shanghai Lung Tumor Clinical Medicine Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.

Department of Stomatology, Ordos central hospital, Ordos, Inner Mongolia, 017000, P. R. China.

出版信息

Cell Death Dis. 2022 Aug 6;13(8):685. doi: 10.1038/s41419-022-05140-w.

DOI:10.1038/s41419-022-05140-w
PMID:35933405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9357013/
Abstract

In view of the important roles played by Kinetochore proteins in mitosis, we believed that they may contribute to the development and progression of human cancers, which has been reported recently elsewhere. Kinetochore-associated 1 (KNTC1) participates in the segregation of sister chromatids during mitosis, the effects of which on non-small-cell lung cancer (NSCLC) remain unclear. Here, we sought to identify the biological significance of KNTC1 in NSCLC. KNTC1 protein expression in NSCLC tissues was investigated by immunohistochemistry. Lentivirus delivered short hairpin RNA (shRNA) was utilized to establish KNTC1 silence NSCLC cell lines. The effects of KNTC1 depletion on NSCLC cell proliferation, migration, apoptosis, and tumor formation were analyzed by MTT assay, wound-healing assay, transwell assay, flow cytometry assay, and in nude mouse models in vivo. After KNTC1 reduction, NSCLC cell viability, proliferation, migration, and invasion were restrained. A xenograft tumor model was also provided to demonstrate the inhibited tumorigenesis in NSCLC. In addition, the downstream mechanism analysis indicated that KNTC1 depletion was positively associated with PSMB8. The findings of the present study suggested that KNTC1 may have a pivotal role in mediating NSCLC progression and may act as a novel therapeutic target for NSCLC.

摘要

鉴于动粒蛋白在有丝分裂中的重要作用,我们认为它们可能有助于人类癌症的发展和进展,这在最近的其他地方也有报道。动粒相关蛋白 1(KNTC1)参与有丝分裂过程中姐妹染色单体的分离,其对非小细胞肺癌(NSCLC)的影响尚不清楚。在这里,我们试图确定 KNTC1 在 NSCLC 中的生物学意义。通过免疫组织化学检测 NSCLC 组织中 KNTC1 蛋白的表达。利用慢病毒递送短发夹 RNA(shRNA)建立 KNTC1 沉默 NSCLC 细胞系。通过 MTT 检测、划痕愈合检测、Transwell 检测、流式细胞术检测和体内裸鼠模型分析 KNTC1 耗竭对 NSCLC 细胞增殖、迁移、凋亡和肿瘤形成的影响。在 KNTC1 减少后,NSCLC 细胞活力、增殖、迁移和侵袭受到抑制。还提供了一个异种移植肿瘤模型来证明 NSCLC 中肿瘤发生的抑制。此外,下游机制分析表明 KNTC1 的缺失与 PSMB8 呈正相关。本研究的结果表明,KNTC1 可能在介导 NSCLC 进展中起关键作用,并可能成为 NSCLC 的一种新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/cad829af0fbc/41419_2022_5140_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/39f185cad3d6/41419_2022_5140_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/12774a37cbaf/41419_2022_5140_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/87c81512cace/41419_2022_5140_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/1861590e2468/41419_2022_5140_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/cad829af0fbc/41419_2022_5140_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/39f185cad3d6/41419_2022_5140_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/12774a37cbaf/41419_2022_5140_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/87c81512cace/41419_2022_5140_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/1861590e2468/41419_2022_5140_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc66/9357013/cad829af0fbc/41419_2022_5140_Fig5_HTML.jpg

相似文献

1
shRNA‑mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8.shRNA 介导的 KNTC1 敲低通过调节 PSMB8 抑制非小细胞肺癌。
Cell Death Dis. 2022 Aug 6;13(8):685. doi: 10.1038/s41419-022-05140-w.
2
shRNA‑mediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.shRNA 介导的 KNTC1 敲低抑制食管鳞状细胞癌细胞活力并诱导细胞凋亡。
Int J Oncol. 2019 Mar;54(3):1053-1060. doi: 10.3892/ijo.2019.4672. Epub 2019 Jan 3.
3
Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.沉默 KNTC1 通过抑制 PI3K/Akt 通路抑制肝癌细胞的进展。
Cell Signal. 2023 Jan;101:110498. doi: 10.1016/j.cellsig.2022.110498. Epub 2022 Oct 21.
4
Long noncoding RNA PSMA3‑AS1 functions as a microRNA‑409‑3p sponge to promote the progression of non‑small cell lung carcinoma by targeting spindlin 1.长链非编码 RNA PSMA3-AS1 通过靶向纺锤体蛋白 1 作为 microRNA-409-3p 的海绵促进非小细胞肺癌的进展。
Oncol Rep. 2020 Oct;44(4):1550-1560. doi: 10.3892/or.2020.7693. Epub 2020 Jul 15.
5
Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.长链非编码 RNA PVT1 的敲低通过调节 miR-497 的表达抑制非小细胞肺癌的肿瘤发生。
Exp Cell Res. 2018 Jan 1;362(1):172-179. doi: 10.1016/j.yexcr.2017.11.014. Epub 2017 Nov 11.
6
Kinetochore-associated protein 1 promotes the invasion and tumorigenicity of cervical cancer cells via matrix metalloproteinase-2 and matrix metalloproteinase-9.着丝粒相关蛋白 1 通过基质金属蛋白酶-2 和基质金属蛋白酶-9 促进宫颈癌的侵袭和致瘤性。
Bioengineered. 2022 Apr;13(4):9495-9507. doi: 10.1080/21655979.2022.2061144.
7
LINC00184 plays an oncogenic role in non-small cell lung cancer via regulation of the miR-524-5p/HMGB2 axis.LINC00184 通过调控 miR-524-5p/HMGB2 轴在非小细胞肺癌中发挥致癌作用。
J Cell Mol Med. 2021 Nov;25(21):9927-9938. doi: 10.1111/jcmm.16247. Epub 2021 Oct 15.
8
Long non‑coding RNA LINC01748 exerts carcinogenic effects in non‑small cell lung cancer cell lines by regulating the microRNA‑520a‑5p/HMGA1 axis.长链非编码 RNA LINC01748 通过调节 microRNA-520a-5p/HMGA1 轴在非小细胞肺癌细胞系中发挥致癌作用。
Int J Mol Med. 2022 Feb;49(2). doi: 10.3892/ijmm.2021.5077. Epub 2021 Dec 31.
9
Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.敲低长链非编码 RNA DLX6-AS1 通过下调 PRR11 表达和上调 miR-144 抑制非小细胞肺癌细胞增殖、迁移和侵袭,促进细胞凋亡。
Biomed Pharmacother. 2019 Jan;109:1851-1859. doi: 10.1016/j.biopha.2018.09.151. Epub 2018 Nov 26.
10
The role of KNTC1 in the regulation of proliferation, migration and tumorigenesis in colorectal cancer.KNTC1 在结直肠癌细胞增殖、迁移和肿瘤发生中的作用。
Cell Signal. 2023 Aug;108:110728. doi: 10.1016/j.cellsig.2023.110728. Epub 2023 May 23.

引用本文的文献

1
Multifaceted investigations of PSMB8 provides insights into prognostic prediction and immunological target in thyroid carcinoma.对蛋白酶体亚基β型8(PSMB8)的多方面研究为甲状腺癌的预后预测和免疫靶点提供了见解。
PLoS One. 2025 May 7;20(5):e0323013. doi: 10.1371/journal.pone.0323013. eCollection 2025.
2
Integrated Analysis of PSMB8 Expression and Its Potential Roles in Hepatocellular Carcinoma.PSMB8在肝细胞癌中的表达及其潜在作用的综合分析
Dig Dis Sci. 2025 Apr 22. doi: 10.1007/s10620-025-09040-9.
3
FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway.

本文引用的文献

1
Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.沉默 KNTC1 通过抑制 PI3K/Akt 通路抑制肝癌细胞的进展。
Cell Signal. 2023 Jan;101:110498. doi: 10.1016/j.cellsig.2022.110498. Epub 2022 Oct 21.
2
Cancer treatment and survivorship statistics, 2019.2019 年癌症治疗与生存统计
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
3
shRNA‑mediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.
FAM50A作为一种新型预后标志物,通过细胞周期蛋白A2/细胞周期蛋白依赖性激酶2(CylinA2/CDK2)途径调节结肠癌细胞的增殖。
PLoS One. 2025 Feb 25;20(2):e0318776. doi: 10.1371/journal.pone.0318776. eCollection 2025.
4
KNTC1 introduces segmental heterogeneity to mitochondria.KNTC1 给线粒体引入了片段异质性。
Dis Model Mech. 2025 Mar 1;18(3). doi: 10.1242/dmm.052063. Epub 2025 Mar 4.
5
Unveiling CKS2: A Key Player in Aggressive B-Cell Lymphoma Progression and a Target for Synergistic Therapy.揭示 CKS2:侵袭性 B 细胞淋巴瘤进展中的关键因子及协同治疗的新靶点
Cancer Med. 2024 Nov;13(22):e70435. doi: 10.1002/cam4.70435.
6
Investigation on the molecular mechanism of SPA interference with osteogenic differentiation of bone marrow mesenchymal stem cells.探讨 SPA 干扰骨髓间充质干细胞成骨分化的分子机制。
Sci Rep. 2024 Jul 6;14(1):15600. doi: 10.1038/s41598-024-66502-2.
7
Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease.基于纳米颗粒的药物输送在缓解肺癌和慢性阻塞性肺疾病中的应用和进展。
Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2793-2833. doi: 10.1007/s00210-023-02830-w. Epub 2023 Nov 22.
8
Potential 'anti-cancer' effects of esketamine on proliferation, apoptosis, migration and invasion in esophageal squamous carcinoma cells.依托咪酯对食管鳞癌细胞增殖、凋亡、迁移和侵袭的潜在“抗癌”作用。
Eur J Med Res. 2023 Nov 15;28(1):517. doi: 10.1186/s40001-023-01511-x.
9
Comprehensive landscape and future perspective of long noncoding RNAs in non-small cell lung cancer: it takes a village.非小细胞肺癌中长链非编码RNA的综合概况与未来展望:众人拾柴火焰高。
Mol Ther. 2023 Dec 6;31(12):3389-3413. doi: 10.1016/j.ymthe.2023.09.015. Epub 2023 Sep 21.
10
KNTC1 knockdown inhibits proliferation and metastases of liver cancer.敲低KNTC1可抑制肝癌的增殖和转移。
3 Biotech. 2023 Sep;13(9):309. doi: 10.1007/s13205-023-03722-9. Epub 2023 Aug 22.
shRNA 介导的 KNTC1 敲低抑制食管鳞状细胞癌细胞活力并诱导细胞凋亡。
Int J Oncol. 2019 Mar;54(3):1053-1060. doi: 10.3892/ijo.2019.4672. Epub 2019 Jan 3.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
PSMB8 regulates glioma cell migration, proliferation, and apoptosis through modulating ERK1/2 and PI3K/AKT signaling pathways.PSMB8 通过调节 ERK1/2 和 PI3K/AKT 信号通路调控神经胶质瘤细胞的迁移、增殖和凋亡。
Biomed Pharmacother. 2018 Apr;100:205-212. doi: 10.1016/j.biopha.2018.01.170. Epub 2018 Feb 9.
6
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.γ干扰素,非小细胞肺癌和黑色素瘤患者对免疫检查点阻断反应的重要标志物。
Ther Adv Med Oncol. 2018 Jan 18;10:1758834017749748. doi: 10.1177/1758834017749748. eCollection 2018.
7
The biology and management of non-small cell lung cancer.非小细胞肺癌的生物学特性与治疗管理。
Nature. 2018 Jan 24;553(7689):446-454. doi: 10.1038/nature25183.
8
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
9
Non-small cell lung cancer: current treatment and future advances.非小细胞肺癌:当前治疗与未来进展。
Transl Lung Cancer Res. 2016 Jun;5(3):288-300. doi: 10.21037/tlcr.2016.06.07.
10
Cancer treatment and survivorship statistics, 2016.癌症治疗和生存统计,2016 年。
CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2.